Mereo BioPharma Group plc (MREO) Analyst Estimates Annual - Discounting Cash Flows
Mereo BioPharma Group plc
MREO (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2021
12-31
Number of Analysts 3 2 4 8 5 4 2 1
Estimated Revenue
Low 214.3 135.7 65.19 35.09 29.96 14.48 6.79 18.43
Average 214.3 135.7 65.19 35.64 29.96 14.48 6.79 18.43
High 214.3 135.7 65.19 36.19 29.96 14.48 6.79 18.43
Estimated EBITDA
Low -91.59 -58 -27.87 -15.47 -12.8 -6.19 -2.9 -9.42
Average -91.59 -58 -27.87 -15.23 -12.8 -6.19 -2.9 -9.42
High -91.59 -58 -27.87 -15 -12.8 -6.19 -2.9 -9.42
Estimated EBIT
Low -92.61 -58.64 -28.18 -15.64 -12.95 -6.26 -2.93 -9.51
Average -92.61 -58.64 -28.18 -15.4 -12.95 -6.26 -2.93 -9.51
High -92.61 -58.64 -28.18 -15.17 -12.95 -6.26 -2.93 -9.51
Estimated Net Income
Low 5.96 -2.38 -38.98 -4.97 -5.15 -14.52 -5.18 -30.86
Average 5.96 -2.38 5.33 -4.97 -2.94 0 -4.75 -30.86
High 5.96 -2.38 48.73 -4.97 0.736 14.52 -4.32 -30.86
Estimated SGA Expenses
Low 3,010 1,906 916 493 420.9 203.5 95.33 -225.4
Average 3,010 1,906 916 500.7 420.9 203.5 95.33 -225.4
High 3,010 1,906 916 508.5 420.9 203.5 95.33 -225.4
Estimated EPS
Low 0.04 -0.016 -0.264 -0.034 -0.035 -0.098 -0.035 -0.047
Average 0.04 -0.016 -0.02 -0.034 -0.02 -0.049 -0.035 -0.047
High 0.04 -0.016 0.329 -0.034 0.005 0.098 -0.029 -0.047
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us